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Scaling pain threshold with microRNAs 
Tuning pain with a defined microRNA cluster 
1. Laura Cassels,  
2. Yves-Alain Barde 
 
Pain is not something universally enjoyed, especially chronic pain involving nerve 
damage, referred to as neuropathic pain (1). Pain perception can be modulated in a 
variety of ways—for example, by focusing attention on the painful stimulus. On page 
1168 of this issue, Peng et al.(2) report that pain threshold in dorsal root ganglion 
neurons (DRG), which relay peripheral sensory information to the central nervous 
system, can be modulated by mechanisms involving a specific cluster of microRNAs 
(miRNAs). Remarkably, the same cluster also regulates the threshold of neuropathic 
pain in DRG neurons that would not be involved in pain under normal conditions. 
The study provides important new insights into molecular mechanisms that control 
pain threshold, both in normal and pathological conditions. 
Among the multitude of miRNAs expressed in the nervous system, the miR-
183/96/182 miRNA cluster (henceforth, miR-183 cluster) is expressed in DRG (3). 
The cluster is also found in a few other sensory organs. In addition, DRG expression 
of miR-183 is reduced in models of chronic pain (4–6). Experimentally, the key 
feature of the study by Peng et al. is the generation of a mouse line that permits the 
selective excision of the miR-183 cluster. This line was crossed with other mouse 
strains, allowing the conditional elimination of the cluster either in all DRG neurons, 
or in a subpopulation of DRG pain-responsive neurons (so-called nociceptors), or in 
another subpopulation of DRG neurons exquisitely sensitive to touch, called low-
threshold mechanoreceptors. Through free nerve endings in the skin, nociceptors 
detect potentially harmful stimuli like heat or noxious chemicals. These endings have 
a high threshold for mechanical stimuli, whereas mechanoreceptors respond to light 
touch, in particular through specialized endings that wrap hair follicles (7). In normal 
animals, sensitivity to mechanical but not to other stimuli was markedly increased 
when the miR-183 cluster was deleted from nociceptors, suggesting that these mi 
RNAs tune mechanical sensitivity. In an established model of neuropathic pain 
generated by a peripheral nerve lesion, the authors showed that deletion of the same 
miRNA cluster in mechanoreceptors markedly increased the response to mechanical 
stimuli. This increased sensitivity is thought to form the basis of chronic pain seen in 
neuropathic pain states through a circuitry involving the spinal cord (1), where 
mechanoreceptors make contact in more-anterior layers compared to nociceptors 
(see the figure). 
An attractive feature of miRNAs is that they typically have multiple targets, such that 
entire pathways can be modulated. At the same time, this feature also makes the 
results of miRNA overexpression paradigms difficult to interpret, hence the value of 
the approach used by Peng et al. In particular, it allows meaningful transcriptional 
analyses to be performed using RNA extracted from the DRG after depletion of the 
miR-183 cluster. In control animals, a modest total of about 30 genes were 
dysregulated. Among the most immediately attractive transcripts from a functional 
standpoint were those encoding subunits α2δ associated with voltage-activated 
calcium channels CACNA2D1 and CACNA2D2. Voltage-activated calcium channels 
are critical for the transmission of painful stimuli, and their associated subunits 
facilitate channel transport to the cell surface (8). Remarkably, these channels are 
targets of the calcium-channel inhibitor gabapentin, one of the few available drugs 
widely used in humans to treat neuropathic pain. So the new results by Peng et 
al. integrate well with what is already known in the field, with the crucial addition that 
the expression levels of functionally relevant components are now known to be 
regulated by the miR-183 cluster expressed in DRG sensory neurons. Indeed, 
Peng et al. demonstrate that this cluster is not expressed in appreciable amounts in 
the spinal cord, either during development or in the adult. These findings are all the 
more relevant in that they also seem to apply to humans: Indeed, analyses of RNA 
transcripts extracted from the DRG of more than 200 humans revealed an inverse 
correlation between the levels of the miR-183 cluster and those of channel and 
channel-associated proteins involved in setting pain threshold. 
What about the changes observed in neuropathic pain? In animal models of 
neuropathic pain, expression of miR-183 in the DRG is decreased (4–6), a result 
confirmed and extended by the study of Peng et al., which reports that the miR-183 
cluster targets the vast majority of pain-regulated genes in mice with neuropathic 
pain, including Cacna2d1 and Cacna2d2. This led the authors to test whether 
gabapentin reverses the intensified neuropathic pain phenotype in miR-183 cluster-
deficient mice, which indeed turned out to be the case. In addition, with the 
knowledge that touch-sensitive mechanoreceptors are a major cellular source of 
problems in neuropathic pain, Peng et al. selectively activated these neurons using 
optogenetics. In control animals, this maneuver did not cause pain. By contrast, in 
the animal model of neuropathic pain, light activation of the same subpopulation of 
neurons increased pain-related behaviors, which could be attenuated by the 
administration of gabapentin. 
The study by Peng et al. offers a remarkably detailed and specific molecular analysis 
of pain-related mechanisms taking place in the DRG. It provides new insights into 
regulatory changes occurring in DRG related to the detection of external stimuli and 
the changes following peripheral nerve lesion. An immediate question for future 
experiments is what regulates expression of the miR-183 cluster. Peng et al. report 
that expression of the miR-183 cluster is substantially higher during early mouse 
development than in the adult. These levels are decreased in neuropathic pain, but 
little is known about the mechanisms regulating expression of the miR-183 cluster in 
either situation. In addition, the results demonstrating an inverse correlation between 
the abundance of the miR-183 cluster and a number of mRNA transcripts in human 
DRG offer new possibilities for investigating the nature of genetic predisposition to 
pain. Although this is widely appreciated to be the case (1), there is still very little 
knowledge about gene polymorphisms or other changes, such as copy-number 
variations, associated with pain. Correlating the expression levels of relevant DRG 
transcripts with genome-wide polymorphism analyses may help to generate new 
knowledge in this area that in turn may lead to new treatments of conditions affecting 
tens of millions of people worldwide. 
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Scaling pain perception 
A cluster of microRNAs (miR-183) scale the threshold for pain perception in two subsets of 
dorsal root ganglia neurons in the skin—nociceptors and mechanoreceptors. 
 
